Stockscreener 앱 받기
14.88
4.25%
-0.66
전일 마감가:
$15.54
열려 있는:
$15.62
하루 거래량:
236.24K
Relative Volume:
0.59
시가총액:
$538.66M
수익:
$2.07M
순이익/손실:
$-47.68M
주가수익비율:
-5.2766
EPS:
-2.82
순현금흐름:
$-31.31M
1주 성능:
-8.60%
1개월 성능:
-0.67%
6개월 성능:
+86.70%
1년 성능:
+253.44%
1일 변동 폭
$14.82
$15.81
1주일 범위
$14.82
$16.37
52주 변동 폭
$3.70
$16.97
Delcath Systems Inc Stock (DCTH) Company Profile
명칭
Delcath Systems Inc
전화
(518) 743-8892
주소
566 QUEENSBURY AVENUE, QUEENSBURY, NY
DCTH을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DCTH
Delcath Systems Inc
|
14.88 | 538.66M | 2.07M | -47.68M | -31.31M | -2.82 |
|
ABT
Abbott Laboratories
|
134.92 | 234.01B | 41.95B | 13.40B | 6.49B | 7.65 |
|
BSX
Boston Scientific Corp
|
104.49 | 154.20B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
382.78 | 146.06B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
89.94 | 115.42B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
73.30 | 43.23B | 5.72B | 4.17B | 490.10M | 6.97 |
Delcath Systems Inc Stock (DCTH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-06-28 | 개시 | Craig Hallum | Buy |
| 2024-05-14 | 개시 | Stephens | Overweight |
| 2022-07-26 | 재개 | Canaccord Genuity | Buy |
| 2021-12-10 | 개시 | H.C. Wainwright | Buy |
| 2021-03-09 | 개시 | Canaccord Genuity | Buy |
| 2021-01-05 | 개시 | BTIG Research | Buy |
| 2020-06-01 | 개시 | Laidlaw | Buy |
모두보기
Delcath Systems Inc 주식(DCTH)의 최신 뉴스
Where are the Opportunities in (DCTH) - Stock Traders Daily
Liver Cancer Treatment Pioneer Delcath Reports Q4 Earnings: Will Growth Continue? - StockTitan
Intrahepatic Cholangiocarcinoma Market: Analysis - openPR
Here's What Could Help Delcath Systems (DCTH) Maintain Its Recent Price Strength - Nasdaq
Delcath Systems Announces Update To National Comprehensive Cancer Network Clinical Practice Guidelines - Marketscreener.com
Delcath Systems Announces Update to National Comprehensive Cance - WICZ
Major Treatment Breakthrough: NCCN Widens Access to Revolutionary Melanoma Therapy - StockTitan
Are You Looking for a Top Momentum Pick? Why Delcath Systems, Inc. (DCTH) is a Great Choice - MSN
(DCTH) Proactive Strategies - Stock Traders Daily
Delcath Delivers 100% Gain In Less Than 6 Months - RTTNews
Analysts Say Delcath Systems Inc Can Reach $22 In 12 Months - Marketing Sentinel
Delcath Systems: Strong Position In Metastatic Uveal Melanoma, But Broader Growth Challenges Ahead - Seeking Alpha
Wall Street Analysts Think Delcath Systems (DCTH) Could Surge 33.74%: Read This Before Placing a Bet - Nasdaq
How should investors view Delcath Systems Inc (DCTH)? - US Post News
Law Offices of Todd M. Garber Announces Class Action Lawsuit Against Delcath Systems, Inc. - AOL
16,978 Shares in Delcath Systems, Inc. (NASDAQ:DCTH) Acquired by Baader Bank Aktiengesellschaft - MarketBeat
Delcath Systems, Inc. (NASDAQ:DCTH) Short Interest Update - MarketBeat
Why You Should Keep An Eye On Delcath Systems - RTTNews
Delcath Systems (DCTH) is on the Move, Here's Why the Trend Could be Sustainable - Yahoo Finance
Biliary Tract Cancer Market Poised for Significant Growth from - openPR
Liver Cancer Treatment Pioneer Delcath Takes Center Stage at Elite Healthcare Summit - StockTitan
Rosalind Advisors, Inc. Expands Stake in Delcath Systems Inc. - GuruFocus.com
retail investors who own 58% along with institutions invested in Delcath Systems, Inc. (NASDAQ:DCTH) saw increase in their holdings value last week - Yahoo Finance
Delcath Systems, Inc. to Host Earnings Call - ACCESS Newswire
Delcath SystemsSuper Growth Projections - MSN
Delcath Systems (NASDAQ:DCTH) Hits New 1-Year HighTime to Buy? - MarketBeat
Barclays PLC Invests $104,000 in Delcath Systems, Inc. (NASDAQ:DCTH) - Defense World
Delcath Systems Stock Soars to 52-Week High of $15.7 Amidst Surge - Investing.com India
Sensus leads med-tech stock rebound in 2024, year closes with modest sector gain - BioWorld Online
When (DCTH) Moves Investors should Listen - Stock Traders Daily
Delcath Systems stock soars to 52-week high of $13.34 - MSN
Craig Hallum Raises Delcath Systems (NASDAQ:DCTH) Price Target to $21.00 - Defense World
Delcath Systems (NASDAQ:DCTH) Price Target Raised to $21.00 - MarketBeat
Delcath Systems, Inc.'s (NASDAQ:DCTH) P/S Is Still On The Mark Following 31% Share Price Bounce - Simply Wall St
Delcath Systems, Inc. (NASDAQ:DCTH) Short Interest Down 23.0% in December - Defense World
Delcath Systems stock retains Buy rating as Craig-Hallum raises price target by 17% - MSN
Delcath Systems stock soars to 52-week high of $13.34 By Investing.com - Investing.com Canada
Delcath Systems, Inc. (NASDAQ:DCTH) Sees Large Decrease in Short Interest - MarketBeat
14 Best 52-Week High Stocks To Buy According to Analysts - Insider Monkey
Top 5 Small-cap Medical Device Stocks (Updated January 2025) - Investing News Network
Delcath Systems, Inc. (DCTH): Analysts Recommend This 52-Week High Stocks Now - Insider Monkey
Delcath Systems Inc (DCTH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Delcath Systems Inc 주식 (DCTH) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Aharon Gil | Director |
Mar 19 '24 |
Buy |
3.72 |
26,882 |
100,001 |
1,069,710 |
| SALAMON STEVEN A J | Director |
Mar 19 '24 |
Buy |
3.72 |
26,882 |
100,001 |
1,121,025 |
1.16%
0.10%
자본화:
|
볼륨(24시간):